COMMUNITY HEALTH SYSTEMS, INC. (CYH) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.08%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.08% | Share-based compensation / revenue. Period ending 2026-06-30. $9.00M ÷ $11.98B × 100 ≈ 0.08% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 11.98B USD | |
| Stock-based compensation | 9.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.36B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.98B | $9.00M | $1.36B | (m) | (m) | 0.08% | (m) | (m) |
| 2026-03-31 | (m) | $12.29B | $10.00M | $1.49B | (m) | (m) | 0.08% | (m) | (m) |
| 2025-12-31 | (m) | $12.48B | $11.00M | $1.49B | (m) | (m) | 0.09% | (m) | (m) |
| 2025-09-30 | (m) | $12.64B | $12.00M | $1.32B | (m) | (m) | 0.09% | (m) | (m) |
| 2025-06-30 | (m) | $12.65B | $16.00M | $869.00M | (m) | (m) | 0.13% | (m) | (m) |
| 2025-03-31 | (m) | $12.65B | $15.00M | $595.00M | (m) | (m) | 0.12% | (m) | (m) |
| 2024-12-31 | (m) | $12.63B | $17.00M | $542.00M | (m) | (m) | 0.13% | (m) | (m) |
| 2024-09-30 | (m) | $12.55B | $18.00M | $591.00M | (m) | (m) | 0.14% | (m) | (m) |
| 2024-06-30 | (m) | $12.55B | $20.00M | $968.00M | (m) | (m) | 0.16% | (m) | (m) |
| 2024-03-31 | (m) | $12.52B | $22.00M | $978.00M | (m) | (m) | 0.18% | (m) | (m) |
| 2023-12-31 | (m) | $12.49B | $22.00M | $957.00M | (m) | (m) | 0.18% | (m) | (m) |
| 2023-09-30 | (m) | $12.45B | $22.00M | $859.00M | (m) | (m) | 0.18% | (m) | (m) |
| 2023-06-30 | (m) | $12.39B | $22.00M | $889.00M | (m) | (m) | 0.18% | (m) | (m) |
| 2023-03-31 | (m) | $12.21B | $21.00M | $761.00M | (m) | (m) | 0.17% | (m) | (m) |
| 2022-12-31 | (m) | $12.21B | $20.00M | $821.00M | (m) | (m) | 0.16% | (m) | (m) |
| 2022-09-30 | (m) | $12.30B | $21.00M | $1.02B | (m) | (m) | 0.17% | (m) | (m) |
| 2022-06-30 | (m) | $12.39B | $20.00M | $1.15B | (m) | (m) | 0.16% | (m) | (m) |
| 2022-03-31 | (m) | $12.47B | $22.00M | $1.35B | (m) | (m) | 0.18% | (m) | (m) |
| 2021-12-31 | (m) | $12.37B | $25.00M | $1.40B | (m) | (m) | 0.20% | (m) | (m) |
| 2021-09-30 | (m) | $12.25B | $23.00M | $1.41B | (m) | (m) | 0.19% | (m) | (m) |
| 2021-06-30 | (m) | $12.27B | $21.00M | $1.36B | (m) | (m) | 0.17% | (m) | (m) |
| 2021-03-31 | (m) | $11.78B | $19.00M | $1.34B | (m) | (m) | 0.16% | (m) | (m) |
| 2020-12-31 | (m) | $11.79B | $13.00M | $1.13B | (m) | (m) | 0.11% | (m) | (m) |
| 2020-09-30 | (m) | $11.96B | $10.00M | $854.00M | (m) | (m) | 0.08% | (m) | (m) |
| 2020-06-30 | (m) | $12.07B | $9.00M | $755.00M | (m) | (m) | 0.07% | (m) | (m) |
| 2020-03-31 | (m) | $12.86B | $9.00M | $571.00M | (m) | (m) | 0.07% | (m) | (m) |
| 2019-12-31 | (m) | $13.21B | $10.00M | $650.00M | (m) | (m) | 0.08% | (m) | (m) |
| 2019-09-30 | (m) | $13.38B | $11.00M | $370.00M | (m) | (m) | 0.08% | (m) | (m) |
| 2019-06-30 | (m) | $13.58B | $12.00M | $259.00M | (m) | (m) | 0.09% | (m) | (m) |
| 2019-03-31 | (m) | $13.84B | $12.00M | $185.00M | (m) | (m) | 0.09% | (m) | (m) |
| 2018-12-31 | (m) | $14.15B | $13.00M | $208.00M | (m) | (m) | 0.09% | (m) | (m) |
| 2018-09-30 | (m) | (m) | $14.00M | $-1.83B | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $16.00M | $-1.81B | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $19.00M | $-1.74B | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $24.00M | $-1.88B | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | $30.00M | $349.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $35.00M | $405.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $41.00M | $-1.08B | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $46.00M | $-860.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $51.00M | $-788.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $55.00M | $-585.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $59.00M | $1.23B | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $59.00M | $1.34B | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $62.00M | $1.68B | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $62.00M | $1.70B | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $57.00M | $1.60B | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $54.00M | $1.38B | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | $45.40M | $1.14B | $877.12M | (m) | (m) | 1.30× | Reported |
| 2014-06-30 | (m) | (m) | $41.40M | $919.76M | $783.15M | (m) | (m) | 1.17× | Reported |
| 2014-03-31 | (m) | (m) | $39.40M | $786.76M | $683.15M | (m) | (m) | 1.15× | Reported |
| 2013-12-31 | (m) | (m) | $38.40M | $899.76M | $615.15M | (m) | (m) | 1.46× | Reported |
| 2013-09-30 | (m) | (m) | $39.13M | $947.55M | $626.32M | (m) | (m) | 1.51× | Reported |
| 2013-06-30 | (m) | (m) | $39.70M | $1.07B | $630.56M | (m) | (m) | 1.69× | Reported |
| 2013-03-31 | (m) | (m) | $40.36M | $1.15B | $627.11M | (m) | (m) | 1.83× | Reported |
| 2012-12-31 | (m) | (m) | $40.90M | $1.21B | $622.93M | (m) | (m) | 1.94× | Reported |
| 2012-09-30 | (m) | (m) | $41.66M | $1.21B | $620.83M | (m) | (m) | 1.95× | Reported |
| 2012-06-30 | (m) | (m) | $42.43M | $1.20B | $621.74M | (m) | (m) | 1.94× | Reported |
| 2012-03-31 | (m) | (m) | $43.12M | $1.20B | $633.37M | (m) | (m) | 1.90× | Reported |
| 2011-12-31 | (m) | (m) | $42.54M | $1.13B | $644.41M | (m) | (m) | 1.76× | Reported |
| 2011-09-30 | (m) | (m) | $40.47M | $1.13B | $654.80M | (m) | (m) | 1.73× | Reported |
| 2011-06-30 | (m) | (m) | $39.09M | $1.13B | $658.19M | (m) | (m) | 1.72× | Reported |
| 2011-03-31 | (m) | (m) | $38.93M | $1.12B | $655.74M | (m) | (m) | 1.71× | Reported |
| 2010-12-31 | (m) | (m) | $38.78M | $1.11B | $651.93M | (m) | (m) | 1.71× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $44.50M | $1.07B | $648.96M | (m) | (m) | 1.65× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $52.10M | $971.88M | $652.47M | (m) | (m) | 1.49× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |